Yunnan Hongxiang Yixintang (002727) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yunnan Hongxiang Yixintang (002727) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥527.92 Million ≈ $77.25 Million USD) by net assets (CN¥7.47 Billion ≈ $1.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yunnan Hongxiang Yixintang (002727) market capitalisation for the company's overall valuation and market capitalisation.
Yunnan Hongxiang Yixintang - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Yunnan Hongxiang Yixintang's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yunnan Hongxiang Yixintang Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yunnan Hongxiang Yixintang ranked by their cash flow conversion efficiency. Explore Yunnan Hongxiang Yixintang cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
0.009x |
|
Zhe Jiang Headman Machinery Co Ltd
SHG:688577
|
0.075x |
|
Hubei Jiuzhiyang Infrared System Co Ltd
SHE:300516
|
0.011x |
|
Aebi Schmidt Holding AG - Common Stock
NASDAQ:AEBI
|
-0.022x |
|
Nanjing Xinlian Electronics Co Ltd
SHE:002546
|
0.029x |
|
Fujian Septwolves Industry Co Ltd
SHE:002029
|
0.002x |
|
Sana Biotechnology Inc
NASDAQ:SANA
|
-0.212x |
|
Newsmax, Inc.
NYSE:NMAX
|
-0.212x |
Annual Cash Flow Conversion Efficiency for Yunnan Hongxiang Yixintang (2009–2025)
The table below shows the annual cash flow conversion efficiency of Yunnan Hongxiang Yixintang from 2009 to 2025. View Yunnan Hongxiang Yixintang stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
CN¥1.63 Billion ≈ $239.02 Million |
0.219x | -2.57% |
| 2024-12-31 | CN¥7.65 Billion ≈ $1.12 Billion |
CN¥1.72 Billion ≈ $251.77 Million |
0.225x | -16.29% |
| 2023-12-31 | CN¥7.88 Billion ≈ $1.15 Billion |
CN¥2.12 Billion ≈ $309.54 Million |
0.269x | -19.05% |
| 2022-12-31 | CN¥7.53 Billion ≈ $1.10 Billion |
CN¥2.50 Billion ≈ $365.40 Million |
0.332x | +23.54% |
| 2021-12-31 | CN¥6.67 Billion ≈ $976.40 Million |
CN¥1.79 Billion ≈ $262.18 Million |
0.269x | +50.20% |
| 2020-12-31 | CN¥5.78 Billion ≈ $845.87 Million |
CN¥1.03 Billion ≈ $151.21 Million |
0.179x | -16.41% |
| 2019-12-31 | CN¥4.60 Billion ≈ $672.56 Million |
CN¥982.92 Million ≈ $143.83 Million |
0.214x | +36.22% |
| 2018-12-31 | CN¥4.05 Billion ≈ $592.57 Million |
CN¥635.77 Million ≈ $93.03 Million |
0.157x | +48.26% |
| 2017-12-31 | CN¥3.69 Billion ≈ $540.54 Million |
CN¥391.16 Million ≈ $57.24 Million |
0.106x | +37.32% |
| 2016-12-31 | CN¥2.50 Billion ≈ $365.55 Million |
CN¥192.63 Million ≈ $28.19 Million |
0.077x | -5.65% |
| 2015-12-31 | CN¥2.27 Billion ≈ $332.61 Million |
CN¥185.76 Million ≈ $27.18 Million |
0.082x | -3.41% |
| 2014-12-31 | CN¥2.08 Billion ≈ $304.77 Million |
CN¥176.22 Million ≈ $25.79 Million |
0.085x | -61.07% |
| 2013-12-31 | CN¥1.05 Billion ≈ $153.67 Million |
CN¥228.22 Million ≈ $33.40 Million |
0.217x | +11.76% |
| 2012-12-31 | CN¥810.77 Million ≈ $118.64 Million |
CN¥157.67 Million ≈ $23.07 Million |
0.194x | +20.41% |
| 2011-12-31 | CN¥628.80 Million ≈ $92.01 Million |
CN¥101.55 Million ≈ $14.86 Million |
0.162x | -24.85% |
| 2010-12-31 | CN¥497.43 Million ≈ $72.79 Million |
CN¥106.90 Million ≈ $15.64 Million |
0.215x | +2.05% |
| 2009-12-31 | CN¥262.78 Million ≈ $38.45 Million |
CN¥55.34 Million ≈ $8.10 Million |
0.211x | -- |
About Yunnan Hongxiang Yixintang
Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline pro… Read more